• 首页
  • 期刊简介
  • 编委会
    第六届编委会
  • 投稿须知
    文章要求
    投稿指南
    发表学术论文“五不准”
  • 本刊稿约
  • 期刊公告
  • 联系我们
引用本文:
【打印本页】   【下载PDF全文】     【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3111次   下载 0次 本文二维码信息
码上扫一扫!
分享到: 微信 更多
字体:加大+|默认|缩小-
阿替普酶治疗急性缺血性脑卒中的疗效及预后影响因素分析
孟桃; 刘骅; 蒋萍; 郑丽华; 夏坤伟
宜宾市第二人民医院神经内科
摘要:
目的观察阿替普酶静脉溶栓治疗急性缺血性脑卒中的疗效,分析阿替普酶治疗急性缺血性脑卒中预后的影响因素。方法回顾性分析2015年7月至2016年7月于我院接受阿替普酶静脉溶栓治疗的急性缺血性脑卒中患者37例临床资料,用NIHSS评分评价患者神经功能缺损程度,用mRS评分评价患者预后,并分析影响溶栓治疗预后的因素。结果阿替普酶治疗前和治疗后24h NIHSS评分差异有统计学意义(P<0.05)。阿替普酶治疗后3个月,预后良好组21例,预后不良组16例,分析得出入院时收缩压、溶栓前NIHSS评分、发病至溶栓开始时间是影响阿替普酶治疗预后的独立危险因素。结论阿替普酶静脉溶栓治疗急性缺血性卒中能明显改善患者神经功能缺损程度,改善患者预后。入院时收缩压、溶栓前NIHSS评分、发病至溶栓开始时间是影响阿替普酶治疗预后的独立危险因素。
关键词:  阿替普酶  急性缺血性卒中  疗效  预后
DOI:
分类号:
基金项目:
Efficacy and Prognostic Factors of Alteplase in the Treatment of Acute Ischemic Stroke
Meng Tao;Liu Hua;Jiang Ping
The Second People’s Hospital of Yibin
Abstract:
Objective To observe the efficacy of alteplase,an intravenous thrombolytic drug,on acute ischemic stroke,and to analyze the influencing factors of the effect of alteplase on the prognosis of acute ischemic stroke.Methods We retrospectively analyzed the clinical data of 37 patients with acute ischemic stroke treated with intravenous thrombolytic therapy of alteplase from July 2015 to July 2016 in our hospital.The NIHSS score was used to evaluate the degree of neurological deficit in patients.The prognosis was evaluated by mRS score and the influencing factors of prognosis were analyzed. Results The difference of NIHSS score between the two groups before and after treatment was statistically significant( P<0. 05).After 3 months of treatment with alteplase,21 patients had good prognosis and 16 patients had poor prognosis.Systolic blood pressure on admission,NIHSS score before thrombolytic therapy,and time of thrombolytic therapy were independent risk factors that affects the prognosis.Conclusion Intravenous thrombolytic drug alteplase can significantly improve the degree of neurological deficit and improve the prognosis of patients with acute ischemic stroke.Systolic blood pressure on admission,NIHSS score before thrombolytic therapy,and time of thrombolytic therapy were independent risk factors of the effect of alteplase on the prognosis of acute ischemic stroke.
Key words:  alteplase  acuteischemicstroke  efficacy  prognosis
您是本站第  88052510  位访问者!蜀ICP备11024768号
版权所有:(C)四川省医疗卫生服务指导中心 2010 CopyRight http://scmj.scyx.org.cn/ all right reserved.
地址:成都市玉林南街2号附3号   电话:028-86136765 邮编:610041
技术支持:北京勤云科技发展有限公司